CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

MRNAModerna, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $192.57 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$76.88B
RECENT INSIDER TRADES
  • 2026-10-07 · Mock James M (Chief Financial Officer) · OTHER
  • 2026-09-16 · Hoge Stephen (President) · OTHER
  • 2026-09-16 · Hoge Stephen (President) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders848
Shares held395,647,591
Value$26.36B
Percent of shares outstanding99.10%
As of quarter end2026-06-30
RECENT NEWS
  • Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
  • Moderna gains 14% to set fresh 52-week high
  • Moderna Stock Skyrockets on Reports of U.S. Cancer Vaccine Initiative
  • Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
  • Moderna stock hits 52-week high at $212.53
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Moderna, Inc. (MRNA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit